Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Encephalitis | 2 | 2025 | 137 | 1.390 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2024 | 14 | 0.900 |
Why?
|
| Neurofilament Proteins | 1 | 2024 | 52 | 0.880 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2024 | 99 | 0.870 |
Why?
|
| Cognitive Dysfunction | 2 | 2024 | 385 | 0.740 |
Why?
|
| Cerebral Veins | 1 | 2021 | 16 | 0.710 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2023 | 257 | 0.700 |
Why?
|
| Central Nervous System Diseases | 1 | 2021 | 69 | 0.670 |
Why?
|
| Microvessels | 1 | 2021 | 85 | 0.670 |
Why?
|
| Cerebral Hemorrhage | 1 | 2021 | 112 | 0.670 |
Why?
|
| Hashimoto Disease | 1 | 2019 | 13 | 0.640 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 186 | 0.610 |
Why?
|
| Sarcoidosis | 1 | 2021 | 159 | 0.610 |
Why?
|
| Down Syndrome | 4 | 2024 | 490 | 0.530 |
Why?
|
| Hemoglobin SC Disease | 1 | 2016 | 13 | 0.510 |
Why?
|
| Nystagmus, Pathologic | 1 | 2016 | 13 | 0.510 |
Why?
|
| Embolism, Fat | 1 | 2016 | 11 | 0.510 |
Why?
|
| Consciousness Disorders | 1 | 2016 | 20 | 0.510 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2016 | 15 | 0.510 |
Why?
|
| Cerebral Infarction | 1 | 2016 | 43 | 0.500 |
Why?
|
| Multiple Organ Failure | 1 | 2016 | 127 | 0.480 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 170 | 0.460 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 153 | 0.460 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 2 | 2024 | 17 | 0.430 |
Why?
|
| Biomarkers | 1 | 2024 | 4158 | 0.400 |
Why?
|
| Multiple Sclerosis | 3 | 2024 | 456 | 0.400 |
Why?
|
| Ventricular Fibrillation | 1 | 2013 | 60 | 0.400 |
Why?
|
| Autoantibodies | 2 | 2023 | 1500 | 0.400 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2013 | 250 | 0.330 |
Why?
|
| Epilepsy | 2 | 2023 | 332 | 0.300 |
Why?
|
| Seizures | 3 | 2025 | 430 | 0.260 |
Why?
|
| Child | 9 | 2025 | 21968 | 0.240 |
Why?
|
| Adolescent | 8 | 2024 | 21463 | 0.230 |
Why?
|
| Atrophy | 1 | 2025 | 184 | 0.230 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2024 | 26 | 0.220 |
Why?
|
| Paraneoplastic Syndromes, Nervous System | 1 | 2023 | 12 | 0.210 |
Why?
|
| Laryngismus | 1 | 2023 | 9 | 0.210 |
Why?
|
| Dystonia | 1 | 2023 | 25 | 0.210 |
Why?
|
| Neuroglia | 1 | 2024 | 172 | 0.200 |
Why?
|
| Genetic Testing | 2 | 2023 | 452 | 0.200 |
Why?
|
| Piperidines | 1 | 2024 | 205 | 0.200 |
Why?
|
| Case-Control Studies | 3 | 2024 | 3537 | 0.190 |
Why?
|
| Humans | 19 | 2025 | 136783 | 0.180 |
Why?
|
| Electroencephalography | 1 | 2024 | 433 | 0.180 |
Why?
|
| Neuromyelitis Optica | 1 | 2023 | 132 | 0.180 |
Why?
|
| Pyrimidines | 1 | 2024 | 470 | 0.170 |
Why?
|
| Interferon-gamma | 1 | 2023 | 790 | 0.160 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 1054 | 0.160 |
Why?
|
| Male | 9 | 2024 | 67361 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2025 | 3566 | 0.150 |
Why?
|
| Platelet Count | 1 | 2016 | 86 | 0.130 |
Why?
|
| Brain | 2 | 2025 | 2669 | 0.120 |
Why?
|
| Tachycardia | 1 | 2016 | 58 | 0.120 |
Why?
|
| Young Adult | 4 | 2024 | 13126 | 0.120 |
Why?
|
| Neurons | 1 | 2024 | 1583 | 0.120 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2016 | 95 | 0.120 |
Why?
|
| Fatal Outcome | 1 | 2016 | 304 | 0.120 |
Why?
|
| Emergencies | 1 | 2016 | 164 | 0.120 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2015 | 65 | 0.120 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 1998 | 0.110 |
Why?
|
| Overnutrition | 1 | 2015 | 30 | 0.110 |
Why?
|
| Female | 7 | 2025 | 72840 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 2417 | 0.110 |
Why?
|
| Immunotherapy | 3 | 2024 | 640 | 0.110 |
Why?
|
| Dyspnea | 1 | 2016 | 251 | 0.110 |
Why?
|
| Hemoglobins | 1 | 2016 | 353 | 0.110 |
Why?
|
| Retrospective Studies | 7 | 2024 | 15564 | 0.110 |
Why?
|
| Glucose Intolerance | 1 | 2015 | 146 | 0.100 |
Why?
|
| Swine | 2 | 2013 | 773 | 0.100 |
Why?
|
| Cardiac Output | 1 | 2013 | 164 | 0.100 |
Why?
|
| Coronary Circulation | 1 | 2013 | 141 | 0.100 |
Why?
|
| Pulmonary Ventilation | 1 | 2013 | 79 | 0.100 |
Why?
|
| Carotid Arteries | 1 | 2013 | 209 | 0.090 |
Why?
|
| Middle Aged | 3 | 2024 | 33200 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 474 | 0.090 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2010 | 86 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 372 | 0.080 |
Why?
|
| Adult | 3 | 2024 | 37616 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2015 | 1201 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2013 | 1772 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1707 | 0.060 |
Why?
|
| Aging | 1 | 2015 | 1861 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2024 | 11069 | 0.060 |
Why?
|
| Diplopia | 1 | 2023 | 19 | 0.050 |
Why?
|
| Occipital Lobe | 1 | 2023 | 22 | 0.050 |
Why?
|
| Antibodies, Antinuclear | 1 | 2023 | 71 | 0.050 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2023 | 51 | 0.050 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2023 | 132 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 4279 | 0.050 |
Why?
|
| Neuroimaging | 1 | 2024 | 263 | 0.050 |
Why?
|
| Recurrence | 1 | 2023 | 1058 | 0.040 |
Why?
|
| Aged | 1 | 2019 | 23729 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 622 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2024 | 777 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 412 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 886 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2023 | 846 | 0.040 |
Why?
|
| Animals | 3 | 2015 | 36768 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2024 | 1075 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 321 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 240 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 178 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 411 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 389 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2015 | 316 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 663 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 2015 | 287 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 5417 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2015 | 346 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2022 | 6046 | 0.020 |
Why?
|
| Bruch Membrane | 1 | 2010 | 6 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 7583 | 0.020 |
Why?
|
| Laminin | 1 | 2010 | 72 | 0.020 |
Why?
|
| Biomimetics | 1 | 2010 | 44 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2010 | 169 | 0.020 |
Why?
|
| Adsorption | 1 | 2010 | 147 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2010 | 150 | 0.020 |
Why?
|
| Zebrafish | 1 | 2015 | 495 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2010 | 191 | 0.020 |
Why?
|
| Glucose | 1 | 2015 | 1019 | 0.020 |
Why?
|
| Surface Properties | 1 | 2010 | 414 | 0.020 |
Why?
|
| Infant | 1 | 2022 | 9442 | 0.020 |
Why?
|
| Collagen | 1 | 2010 | 445 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 2750 | 0.020 |
Why?
|
| Amino Acids | 1 | 2010 | 500 | 0.020 |
Why?
|
| Peptides | 1 | 2010 | 980 | 0.010 |
Why?
|
| Insulin | 1 | 2015 | 2399 | 0.010 |
Why?
|